| Title |
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
|
|---|---|
| Published in |
Vascular Health and Risk Management, March 2014
|
| DOI | 10.2147/vhrm.s55246 |
| Pubmed ID | |
| Authors |
Sylvia Haas, Christoph Bode, Bo Norrving, Alexander GG Turpie |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 3 | 2% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Slovenia | 1 | <1% |
| Unknown | 146 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 15% |
| Student > Bachelor | 20 | 13% |
| Researcher | 18 | 12% |
| Student > Ph. D. Student | 13 | 9% |
| Student > Doctoral Student | 10 | 7% |
| Other | 36 | 24% |
| Unknown | 32 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 46% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 11% |
| Agricultural and Biological Sciences | 8 | 5% |
| Nursing and Health Professions | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Other | 12 | 8% |
| Unknown | 38 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2022.
All research outputs
#15,305,492
of 25,584,565 outputs
Outputs from Vascular Health and Risk Management
#436
of 785 outputs
Outputs of similar age
#121,456
of 236,752 outputs
Outputs of similar age from Vascular Health and Risk Management
#10
of 16 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 785 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,752 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.